Press release

Siemens Healthineers presents 3D imaging integrated with endoluminal robotics for precise transbronchial lung biopsy

The integration of the capabilities of Siemens Healthineers mobile 3D imaging system Cios Spin with Intuitive’s Ion Endoluminal System for transbronchial biopsy enables automated 3D image transfer to update the target location of the lesion.

Published on July 14, 2022
Download image

The products and features herein are not commercially available in all countries. Future availability cannot be guaranteed.


Casal, R. F., Sarkiss, M., Jones, A. K., Stewart, J., Tam, A., Grosu, H. B., . . . Eapen, G. A. (2018). Cone beam computed tomography-guided thin/ultrathin bronchoscopy for diagnosis of peripheral lung nodules: A prospective pilot study. Journal of Thoracic Disease, 10(12), 6950-6959. doi:10.21037/jtd.2018.11.21


Avasarala, S. K., Machuzak, M. S., & Gildea, T. R. (2020). Multidimensional Precision. Journal of Bronchology & Interventional Pulmonology, 27(2), 153-155. doi:10.1097



Kalchiem-Dekel O, Fuentes P, Bott MJ, Beattie JA, Lee RP, Chawla M, Husta BC. Multiplanar 3D fluoroscopy redefines tool-lesion relationship during robotic-assisted bronchoscopy. Respirology. 2021;26(1):120-123


Reisenauer J et al. Combining Shape-Sensing Robotic Bronchoscopy With Mobile Three-Dimensional Imaging to Verify Tool-in-Lesion and Overcome Divergence: A Pilot Study. Mayo Clin Proc Inn Qual Out. 2022;6(3):177-185

Siemens Healthineers 2022

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2021, which ended on September 30, 2021, Siemens Healthineers, which has approximately 66,000 employees worldwide, generated revenue of €18.0 billion and adjusted EBIT of €3.1 billion. Further information is available at